COMP <GO>
CTY vs SPTX // ALTMAN Z-SCORE & DEBT/EQUITY
City Therapeutics Inc. (NASDAQ) VS. Seaport Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: CTY 1
— SPTX 1
■ METRIC PARITY
LAST: $22.14 (+2.26%) • MKT CAP: $1.11B
balance-sheet
—
LAST: $21.10 (+3.53%) • MKT CAP: $1.13B
balance-sheet
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CTY VS. SPTX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CTY | SPTX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | — | — | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 61.6 | 48.7 | +12.93 | CTY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.11B | $1.13B | -$15.1M | SPTX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CTY REV | SPTX REV | CTY GROSS % | SPTX GROSS % | CTY FCF | SPTX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $0 | — | — | — | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CTY // BETA —
SPTX // BETA —